Therapeutic possibilities in blood circulatory and lipid metabolism disorders
Schneider, H.
Zeitschrift für Allgemeinmedizin 47(36): 1916-1918
1971
ISSN/ISBN: 0300-8673 PMID: 5003958 Document Number: 37021
Document emailed within 1 workday
Related Documents
Pedziński, W.; Urban, M.; Wójtowicz, J. 1986: Evaluation of the effect of lipid metabolism disorders on circulatory hemodynamics and the elasticity of the vascular wall in children with simple obesity. Ii Kardiologia Polska 29(8): 543-550Okabe, K.; Fujisawa, K.; Takahashi, T. 1970: Therapeutic agents for lipid metabolism disorders--with special reference to fatty liver Nihon Rinsho. Japanese Journal of Clinical Medicine 28: Suppl: 700-3
Stroev, I.I.; Volgin, E.G.; Bodrov, V.E.; Chuchman, A.D. 1976: Changes in elastic and viscous properties of blood vessels in patients with diabetes mellitus and their relationship with disorders of glycoprotein and lipid metabolism Kardiologiia 16(9): 130-132
Staehelin, A. 1977: Treatment possibilities of arterial circulatory disorders using calcitonin Schweizerische Medizinische Wochenschrift 107(49): 1865-1867
Hamada, Y.; Fukagawa, M. 2008: Relationship between lipid and glucose metabolism and bone mineral metabolism : pleiotropic effects of therapeutic agents for diabetes and hyperlipidemia Clinical Calcium 18(5): 671-676
Mölgaard, J.; Olsson, A.G. 1988: Therapeutic possibilities of a newly registered lipid suppressor Lakartidningen 85(40): 3271-3274
Stanek, F.D.; Scheibe, J.; Pöhlmann, G.; Gottschild, D.; Dietze, C. 1987: Sports as a preventive and therapeutic measure in arterial circulatory disorders Zeitschrift für Arztliche Fortbildung 81(24): 1251-1255
Altomonte, L.; Mingrone, G.; Ghirlanda, G.; Manna, R.; Rebuzzi, A.; Pala, M.A.; Greco, A.V. 1980: Bile lipid composition in subjects with blood lipid disorders (types II and IV). Effect of a new hypolipemic drug (Etofibrate) Minerva Medica 71(4): 273-278
Bogoliubov, V.M.; Gabuniia, R.I.; Kruglova, Z.G.; Lyskova, M.N. 1971: Potassium metabolism disorders in circulatory insufficiency according to data from measuring the natural radioactivity of K40 Kardiologiia 11(12): 71-74
Nissen, G. 1978: Therapeutic possibilities in child behavior disorders Die Medizinische Welt 29(35): 1358-1361
Richter, W.O.; Schwandt, P. 1992: Classification of disorders of lipid metabolism Der Internist 33(11): 728-731
Kockott, G. 1989: Diagnostic and therapeutic possibilities in psychological disorders as a cause of impotence Der Urologe. Ausg. a 28(5): 248-252
Elikov, A.V.; Tsapok, P.I. 2012: Relationship between the values of lipid peroxidation, lipid metabolism, and red blood cell osmotic resistance in sportsmen of cyclic and non-cyclic sports Gigiena i Sanitariia 1: 84-87
Herrmann, W.; Biermann, J. 1986: Familial disorders of lipid metabolism in childhood Zeitschrift für Arztliche Fortbildung 80(17): 725-728
Lambert, D.; Dubost, M.; Mugneret, F.; Justrabo, E.; Putelat, R.; Chapuis, J.L. 1975: Elastic pseudoxanthoma associated with lipid metabolism disorders La Nouvelle Presse Medicale 4(15): 1123-1124
Kunze, M.; Schwarz, B. 1990: Epidemiology of atherosclerosis and disorders of lipid metabolism Wiener Medizinische Wochenschrift 140(4): 94-100
Danish, G.I. 1972: Lipid metabolism disorders and atherosclerotic changes in endomyocarditis Vrachebnoe Delo 10: 16-19
Fuhrmann, W. 1974: Genetic aspects of lipid metabolism disorders Münchener Medizinische Wochenschrift 116(22): 1110-1111
Tunian, I.S.; Akopov, S.E.; Bakunts, G.O. 1982: Blood rheological properties in cerebral circulatory disorders Klinicheskaia Meditsina 60(10): 35-39
Gannushkina, I.V.; Antelava, A.L.; Konorova, I.L.; Suslina, Z.A.; Lebedeva, N.V. 1992: Hydrodynamic resistance of blood and possibilities of its correction with special polymers in the blood of patients with ischemic cerebrovascular disorders Gematologiia i Transfuziologiia 37(9-10): 16-19